Fevertree Drinks Plc shares have nearly tripled since its 2014 initial public offering as British hipsters paired its tonic with bespoke gins. Now, the question is whether they can keep their fizz.
The London-based company’s shares have traded above their target price since the beginning of the month, with full-year earnings due March 21. Despite its vertiginous rise, the stock still has a buy rating from five of the six analysts covering it.
